ArticleCancer biomarkers : section A of Disease markers2022

TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.

Luís Alberto de Pádua Covas Lage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.